Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
Jae Chol Choi, Sun‐Young Jung, Una Amelia Yoon, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3406-3406
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 7, pp. 763-772
Open Access | Times Cited: 386
Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea
Sang Chul Lee, Kang Ju Son, Chang Hoon Han, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 88
The Complex Association between COPD and COVID-19
Nikhil T Awatade, Peter Wark, Andrew S. L. Chan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3791-3791
Open Access | Times Cited: 25
Using Quantitative Bias Analysis to Adjust for Misclassification of COVID‐19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID‐19 Outcomes
Marleen Bokern, Christopher T. Rentsch, Jennifer K Quint, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies
Helene F. Rosenberg, Paul S. Foster
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 383-392
Open Access | Times Cited: 55
Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID
Manuela Funke-Chambour, Pierre‐Olivier Bridevaux, Christian F. Clarenbach, et al.
Respiration (2021) Vol. 100, Iss. 8, pp. 826-841
Open Access | Times Cited: 50
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David Halpin, Adrian Paul J. Rabe, Wei Jie Loke, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 811-825
Open Access | Times Cited: 29
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.
Mohammad Amin Langarizadeh, Marziye Ranjbar Tavakoli, Ardavan Abiri, et al.
EXCLI journal (2021) Vol. 20, pp. 339-365
Closed Access | Times Cited: 38
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis
Bohee Lee, Grace Lewis, Eldad Agyei‐Manu, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220066-220066
Open Access | Times Cited: 27
A retrospective study regarding the influence of COVID-19 disease on asthma
Ioana Adriana Muntean, Polliana Mihaela Leru, Irena Pintea, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Exploring Asthma as a Protective Factor in COVID-19 Outcomes
Anthony E. Quinn, Lei Zhao, Scott D. Bell, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1678-1678
Open Access
Association of Inhaled Corticosteroid Use with COVID-19 Severity and Hospitalization in Patients With and Without Respiratory Disease
Michal Leibovitch, Tsz‐Kwong Man, Jacob Cohen, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery (2025)
Closed Access
The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis
Chao‐Hsien Chen, Cheng‐Yi Wang, Ching-Yi Chen, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0295366-e0295366
Open Access | Times Cited: 3
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
Vincenzo Lariccia, Simona Magi, Tiziano Serfilippi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 4021-4021
Open Access | Times Cited: 26
Inhaled corticosteroids for the treatment of COVID-19
Mona Bafadhel, Rosa Faner, Camille Taillé, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220099-220099
Open Access | Times Cited: 15
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
Martin Sebastian Winkler, Tomasz Skirecki, Frank M. Brunkhorst, et al.
EBioMedicine (2021) Vol. 66, pp. 103291-103291
Open Access | Times Cited: 19
Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Yehudis Rosenwasser, Irene Berger, Zvi G. Loewy
Pathogens (2022) Vol. 11, Iss. 12, pp. 1513-1513
Open Access | Times Cited: 13
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register
Johanna Karlsson Sundbaum, Jon R. Konradsen, Lowie E.G.W. Vanfleteren, et al.
Therapeutic Advances in Respiratory Disease (2022) Vol. 16
Open Access | Times Cited: 12
Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19: a meta-analysis
Chia Siang Kow, Syed Shahzad Hasan
Journal of Asthma (2021) Vol. 59, Iss. 4, pp. 787-790
Closed Access | Times Cited: 12
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study
Khalid Al Sulaiman, Ohoud Aljuhani, Kholoud Al Aamer, et al.
Journal of Intensive Care Medicine (2021) Vol. 37, Iss. 2, pp. 248-257
Open Access | Times Cited: 12
Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era
C. W. David Chang, Edward D. McCoul, Selena E. Briggs, et al.
Otolaryngology (2021) Vol. 167, Iss. 5, pp. 803-820
Closed Access | Times Cited: 12
Progression of Corticosteroid Use in Patients with Chronic Obstructive Pulmonary Disease during the Pandemic of Novel Coronavirus Infection
东旭 沈
Advances in Clinical Medicine (2024) Vol. 14, Iss. 07, pp. 525-529
Closed Access | Times Cited: 1
Characterization of COPD Admissions During the First COVID-19 Outbreak
Borja G. Cosío, Hanaa Shafiek, Nuria Toledo‐Pons, et al.
International Journal of COPD (2021) Vol. Volume 16, pp. 1549-1554
Open Access | Times Cited: 10
The association of preexisting severe asthma with COVID-19 outcomes
Paul Terry, R. Eric Heidel, Rajiv Dhand
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 3, pp. 215-222
Open Access | Times Cited: 3
Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry
Noam Zevit, Mirna Chehade, John Leung, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 1, pp. 143-149.e9
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top